pubmed-article:12011122 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0079731 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0439682 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0877880 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
pubmed-article:12011122 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
pubmed-article:12011122 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:12011122 | pubmed:dateCreated | 2002-5-15 | lld:pubmed |
pubmed-article:12011122 | pubmed:abstractText | Radioimmunotherapy combines biologic and radiolytic mechanisms to target and destroy tumor cells, thus offering a needed therapeutic alternative for refractory non-Hodgkin's lymphoma (NHL) patients. This phase III randomized study compares the novel radioimmunotherapy yttrium-90 ((90)Y) ibritumomab tiuxetan with a control immunotherapy, rituximab, in 143 patients with relapsed or refractory low-grade, follicular, or transformed CD20(+) transformed NHL. | lld:pubmed |
pubmed-article:12011122 | pubmed:language | eng | lld:pubmed |
pubmed-article:12011122 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12011122 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12011122 | pubmed:month | May | lld:pubmed |
pubmed-article:12011122 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:WitzigThomas... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:WisemanGregor... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:CabanillasFer... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:BartlettNancy... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:GordonLeo ILI | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:CzuczmanMyron... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:Grillo-LópezA... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:Emmanouilides... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:WhiteChristin... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:JoyceRobinR | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:PohlmanBrad... | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:PadreNormanN | lld:pubmed |
pubmed-article:12011122 | pubmed:author | pubmed-author:MultaniPratik... | lld:pubmed |
pubmed-article:12011122 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12011122 | pubmed:day | 15 | lld:pubmed |
pubmed-article:12011122 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:12011122 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12011122 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12011122 | pubmed:pagination | 2453-63 | lld:pubmed |
pubmed-article:12011122 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:meshHeading | pubmed-meshheading:12011122... | lld:pubmed |
pubmed-article:12011122 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12011122 | pubmed:articleTitle | Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. | lld:pubmed |
pubmed-article:12011122 | pubmed:affiliation | Division of Internal Medicine and Hematology, Nuclear Medicine, Mayo Clinic and Mayo Foundation, 60 Stabile Building, Rochester, MN 55905, USA. witzig@mayo.edu | lld:pubmed |
pubmed-article:12011122 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12011122 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12011122 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:12011122 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12011122 | lld:pubmed |